NRXP (NRx Pharmaceuticals, Inc.) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Graphic logo of nrxpharma.com (NRXP)

High R&D expenditures in psychiatry keep the operating leverage of NRx Pharmaceuticals (NRXP) in negative territory. NRx Pharmaceuticals (NRXP) is optimizing the supply of psychotropic drugs through diversified distribution channels to protect margins. This price chart reflects a value of 0.00, while the business relies on developing agents that target NMDA receptors, focusing on therapy reimbursement by insurance companies and clinics.

NRXP (NRx Pharmaceuticals Inc.) Company Value to EBITDA history from 11/23/2025 to 11/15/2026

Comprehensive metric breakdowns and analytics for NRx Pharmaceuticals Inc. (NRXP)

- market price and analyst price targets:
Price Chart NRx Pharma|NRXP - Forecast Levels Chart
- business market valuation indicators:
Market Value NRx Pharma|NRXP - Company Buyout Price
- book value of equity indicators:
Accounting Value per Share NRx Pharmaceuticals|NRXP - Total Stockholders' Equity|Market Capitalization to Book Value Ratio nrxpharma.com|NRXP - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital NRx Pharmaceuticals|NRXP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity nrxpharma.com|NRXP - Company Cumulative Debt|Debt to Book Capitalization Ratio NRx Pharma|NRXP - Company Long-Term Indebtedness|Company Short-Term Debt NRx Pharmaceuticals|Quick Liquidity Indicator nrxpharma.com
- net income and valuation multiples indicators:
NRXP - Company Profit|Future Profit NRx Pharmaceuticals|NRXP - Company Value to Net Income|Future Price to Earnings NRx Pharmaceuticals|NRXP - Market Cap to Earnings and Growth Ratio|EV/EBITDA Multiple NRx Pharmaceuticals Inc.|NRXP - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) NRx Pharmaceuticals|NRXP - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months nrxpharma.com|NRXP - Earnings per share increase in current year|Net earnings per share growth forecast for next year NRx Pharmaceuticals
- revenue and sales details:
NRXP - Company Sales|Projected Sales Volume NRx Pharmaceuticals, Inc|NRXP - P/S Multiple|Forward P/S Multiple NRx Pharmaceuticals Inc.|NRXP - Revenue Growth YoY (Last 12 Months)
Initial company analysis:NRXP (NRx Pharmaceuticals, Inc.)
Product sample of NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals' ability to withstand market downturns currently depends on the effectiveness of the management's restructuring course to stabilize liquidity. The business's EV/EBITDA metric, which has reached 0.00, compares the total enterprise value with operating profit, allowing investors to assess the real value of assets net of debt and determine the company's level of debt risk.

Competitor analysis for NRx Pharmaceuticals

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Alkermes Inc. ALKS|AVDL (avadel.com) - Company Value to Operating Income Before Depreciation Ratio|ATAI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio GH Research Corp GHRS|MNMD (mindmed.co) - Enterprise Value to EBITDA Ratio|Company Value to EBITDA Compass Pathways (CMPS)|LBRX (lbpharma.us) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bright Minds Biosciences (DRUG)|EV/EBITDA Multiple VNDA|CYBN (Cybin Inc) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization altoneuroscience.com ANRO|Cingulate Corp (CING) - Company Value to EBITDA|SILO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|chinapharmaholdings.com (CPHI) - Enterprise Value to EBITDA Ratio|Clearmind Medicine (CMND) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Psyence Biomedical (PBM)|SPRC (SciSparc Corp) - EV/EBITDA Multiple|Company Value to EBITDA Seelos Therapeutics Inc SEEL|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization virpaxpharma.com (VRPX)|EV/EBITDA Multiple karunatx.com (KRTX)